Evonik Corp, Wyatt Technology Corporation, Malvern Panalytical & Drug Delivery Experts
Date/Time: Sunday, July 22, 2018 - 9:45 AM to 10:45 AM
Open to all registered attendees on a complimentary basis, these forums offer in-depth coverage of technologies and services hosted by the presenting companies.
Presented By: Ketaki Patwardhan, Ph.D., Principal Scientist, Products & Formulations, Evonik Health Care
Solid dispersion technologies like spray drying and hot melt extrusion convert poorly soluble crystalline actives into amorphous forms within a polymeric matrix. To stabilize the amorphous form of actives with high states of energy, strong interaction with the polymeric matrix and high glass-transition are important polymer attributes. EUDRAGIT® polymers with inherent ionic and strong H-bonding interactions will be reviewed with comparison to other polymeric systems.
Light scattering addresses many key analytical challenges in drug nanoparticle R&D, including accurate size distributions, conformation, payload and formulation. We review light scattering fundamentals, then present examples illustrating how Wyatt's unique light scattering instrumentation facilitates rapid and effective development of controlled release vehicles including liposomes, VLPs, polymer-encapsulated nanoparticles and nanogels.
Characterizing Controlled Release Vehicles
Using multiple analytical techniques to better understand the properties of CRVs
Presented by: Matt McGann
From quantifying the encapsulation efficiency, to elucidating mechanisms of release, a multifaceted analytical approach to characterizing controlled release vehicles (CRVs) provides better understanding of their properties. In this forum Malvern Panalytical will introduce a range of techniques including DLS, NTA, XRD, GPC, and ITC and demonstrate how these data sets help improve product quality and understanding.
Presented by: Drug Delivery Experts CEO Christopher A. Rhodes, Ph.D.
Drug Delivery Experts (DDE) is a contract R&D drug delivery laboratory located in San Diego's emerging biotech sector that excels in integrating the right formulation, delivery system, and device to fit the therapeutic product need.
DDE was created to address gaps in the formulation and drug delivery technology landscape. While solving our client’s most challenging drug delivery issues, our experts leverage their experiences and backgrounds to develop new delivery technologies.
CEO Christopher A. Rhodes, Ph.D. will speak about what we do best in the areas of Sustained Release Gel Formulation, Peptide Salt Screening and Selection, and Injection Site Reaction Issues, as well as highlight Future Trends in Drug Delivery Technology.
The session is meant to be interactive with a few leading slides for each discussion, so that attendees will have the opportunity to interact and ask questions.